Intellia hits a home run with gene editing results, setting up entire field for a grand slam
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Intellia s early CRISPR trial data validate a drug pipeline and the gene-editing field
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Operator
Good morning. My name is Izzy and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] [Operator Instructions]. Following formal remarks, we will open the call up for questions. This conference is being recorded at the company s request and will be available on the company s website following the end of the call.
I will now turn the conference to Lina Li, Director of Investor Relations at Intellia. Please proceed.
Lina Li
Director, Investor Relations
Thank you, operator. And Good morning, everyone. Welcome to Intellia s first quarter 2021 earnings call. Earlier today, the company issued a press release outlining the company s progress this quarter as well as topics for discussion on today s call. This release can be found on the Investors and Media section of Intellia s website at intelliatx.com. This call is being broadcast live and a replay will also be archived